Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Topical resiquimod elicits systemic protection and improves anti-PD1 therapy in melanoma via priming of CD8+ T cells.

Cancer immunology research·2026

Same author

Melanoma-patient-derived xenograft multi-omics resource melPDomiX maps gain- and loss-of-function alterations.

Cell reports·2026

Same author

Multicentric Asynchronous Endocrine Mucin-Producing Sweat Gland Carcinoma and Mucinous Carcinoma of the Skin.

Journal of cutaneous pathology·2026

Same author

Mohs-facilitated excision: A case series of a multidisciplinary approach to reduce local recurrence of advanced keratinocyte carcinomas.

Journal of the American Academy of Dermatology·2026

Same author

Immune checkpoint blockade in desmoplastic melanoma.

Nature cancer·2026

Same author

Accuracy of Sentinel Lymph Node Biopsy to Predict Nodal Metastasis in Head and Neck Merkel Cell Carcinoma.

JAMA otolaryngology-- head & neck surgery·2026

Same journal

Anti-PD-(L)1 plus chemotherapy in advanced PD-L1-negative nonsquamous non-small cell lung cancer: a systematic review and meta-analysis.

Immunotherapy·2026

Same journal

Anti-TIGIT therapies in digestive cancers: from immune evasion to precision immunotherapy.

Immunotherapy·2026

Same journal

CAR cellular therapies for acute myeloid leukemia: current landscape and future directions.

Immunotherapy·2026

Same journal

Recent advances in bispecific natural killer cell engagers for cancer immunotherapy.

Immunotherapy·2026

Same journal

Exploring global research trends in sublingual immunotherapy of allergic rhinitis: a comprehensive bibliometric analysis.

Immunotherapy·2026

Same journal

Autoimmune encephalitis and axonal polyradiculoneuropathy following therapy with adalimumab and secukinumab: a case report and literature review.

Immunotherapy·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Feb 6, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Immunotherapy in melanoma.

Emily Feld¹, Tara C Mitchell¹

¹UDepartment of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

|August 29, 2018

Summary

This summary is machine-generated.

Immunotherapy has transformed melanoma treatment, offering improved outcomes for advanced cases. This review covers approved immunotherapy drugs, clinical data, side effects, and future research directions for melanoma.

Keywords:

CTLA-4 IL-2 Immunotherapy PD-1 interferon ipilimumab melanoma nivolumab pembrolizumab talimogene laherparepvec

More Related Videos

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes

Published on: November 11, 2016

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

Related Experiment Videos

Last Updated: Feb 6, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes

Published on: November 11, 2016

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

Area of Science:

Oncology
Immunology
Dermatology

Background:

Immunotherapy represents a significant advancement in melanoma treatment.
It is now a primary therapeutic strategy for advanced melanoma.
The application of immunotherapy in melanoma is continually evolving.

Purpose of the Study:

To review currently approved immunotherapy drugs for melanoma.
To summarize clinical trial data, adverse effects, and response assessment.
To discuss future directions in melanoma immunotherapy.

Main Methods:

Literature review of approved immunotherapy agents.
Analysis of clinical trial outcomes and safety profiles.
Synthesis of information on response evaluation and future research.

Main Results:

Several immunotherapy agents are approved for melanoma treatment.
Data on efficacy, toxicity, and patient response are available.
Ongoing research explores novel agents and treatment combinations.

Conclusions:

Immunotherapy has revolutionized melanoma patient prognosis.
Understanding approved agents, their effects, and future potential is crucial.
Continued research will further refine immunotherapy strategies for melanoma.